×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ASMB – assembly biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ASMB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/13
06:42 am
asmb
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates [Yahoo! Finance]
Low
Report
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates [Yahoo! Finance]
11/7
04:05 pm
asmb
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
Low
Report
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
9/24
08:09 am
asmb
Assembly Biosciences, Inc. (NASDAQ: ASMB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
High
Report
Assembly Biosciences, Inc. (NASDAQ: ASMB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
9/23
08:00 am
asmb
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
High
Report
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
9/20
08:12 am
asmb
Assembly Biosciences, Inc. (NASDAQ: ASMB) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $2.00.
Low
Report
Assembly Biosciences, Inc. (NASDAQ: ASMB) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $2.00.
9/16
11:29 am
asmb
Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
8/29
06:48 am
asmb
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week [Yahoo! Finance]
Low
Report
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
5/8/2024
04:05 pm
asmb
assembly biosciences, inc.
BEAT
Report
1.2%
assembly biosciences, inc.
Date
Time
Symbol
Headline
Impact
11/19
04:05 pm
asmb
Form 4 ASSEMBLY BIOSCIENCES, For: Nov 18 Filed by: White Nicole S
Low
Report
Form 4 ASSEMBLY BIOSCIENCES, For: Nov 18 Filed by: White Nicole S
11/14
03:23 pm
asmb
Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC
11/7
04:53 pm
asmb
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 07
Medium
Report
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 07
11/7
04:45 pm
asmb
Form 424B5 ASSEMBLY BIOSCIENCES,
Low
Report
Form 424B5 ASSEMBLY BIOSCIENCES,
11/7
04:27 pm
asmb
Form 10-Q ASSEMBLY BIOSCIENCES, For: Sep 30
Low
Report
Form 10-Q ASSEMBLY BIOSCIENCES, For: Sep 30
11/7
04:17 pm
asmb
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 07
Low
Report
Form 8-K ASSEMBLY BIOSCIENCES, For: Nov 07
10/9
09:15 am
asmb
Form 4 ASSEMBLY BIOSCIENCES, For: Oct 08 Filed by: Schornstein Alexander
Medium
Report
Form 4 ASSEMBLY BIOSCIENCES, For: Oct 08 Filed by: Schornstein Alexander
10/4
04:05 pm
asmb
Form 4 ASSEMBLY BIOSCIENCES, For: Oct 03 Filed by: White Nicole S
Low
Report
Form 4 ASSEMBLY BIOSCIENCES, For: Oct 03 Filed by: White Nicole S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/12
Assembly Biosciences Announces Pricing of $125 Million Public Offering
41.6%
10/15 Assembly Biosciences Inc (NASDAQ: ASMB) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 36.7%
8/7 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer 20.2%
10/16 Here's Why Assembly Biosciences Stock Soared Today [The Motley Fool] 19.3%
9/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 16.2%
4/6 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy 12.3%
7/1 Assembly Biosciences Inc (NASDAQ: ASMB) had its "hold" rating re-affirmed by analysts at Chardan Capital. 9.8%
3/13 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 9.6%
3/26 Form SEC STAFF LETTER ASSEMBLY BIOSCIENCES, 9.2%
6/24 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 7.4%
10/15 Assembly Biosciences Inc (NASDAQ: ASMB) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 36.7%
8/7 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer 20.2%
10/16 Here's Why Assembly Biosciences Stock Soared Today [The Motley Fool] 19.3%
9/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 16.2%
4/6 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy 12.3%
7/1 Assembly Biosciences Inc (NASDAQ: ASMB) had its "hold" rating re-affirmed by analysts at Chardan Capital. 9.8%
3/13 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 9.6%
3/26 Form SEC STAFF LETTER ASSEMBLY BIOSCIENCES, 9.2%
6/24 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 7.4%
TOP News Decliners
11/11
Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019
-18.2%
10/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -11.0%
12/12 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.6%
8/9 Form 8-K ASSEMBLY BIOSCIENCES, For: Aug 06 -10.1%
9/24 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.8%
9/27 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. -7.7%
12/13 Form 424B5 ASSEMBLY BIOSCIENCES, -6.1%
5/10 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: EcoR1 Capital, LLC -4.9%
2/14 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC -3.9%
6/21 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China -3.6%
10/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -11.0%
12/12 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.6%
8/9 Form 8-K ASSEMBLY BIOSCIENCES, For: Aug 06 -10.1%
9/24 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.8%
9/27 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. -7.7%
12/13 Form 424B5 ASSEMBLY BIOSCIENCES, -6.1%
5/10 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: EcoR1 Capital, LLC -4.9%
2/14 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC -3.9%
6/21 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: